High Tide Opens First European Canna Cabana in Berlin

High Tide (Nasdaq: HITI) opened its first European Canna Cabana flagship store in Berlin on December 1, 2025, marking its bricks-and-mortar entry into Germany and Europe.

Rhea-AI Summary

High Tide (Nasdaq: HITI) opened its first European Canna Cabana flagship store in Berlin on December 1, 2025, marking its bricks-and-mortar entry into Germany and Europe.

The store at Alte Schönhauser Str. 2 sits in Berlin-Mitte near Alexanderplatz. The launch follows High Tide's acquisition of Remexian Pharma GmbH, a licensed German medical cannabis importer and distributor, and supports a multi-channel European strategy across retail, e-commerce, and medical distribution.

Key disclosed metrics: 215 domestic Canna Cabana locations, 1 international location, a reported 12% Canadian market share, Remexian licensed to import from 19 countries, and German imports of 143 tonnes in the first three quarters of 2025.

Positive

• Opened Berlin flagship store on Dec 1, 2025
• 215 domestic and 1 international Canna Cabana locations
• Reported 12% Canadian market share
• Remexian licensed to import from 19 countries
• Germany imports 143 tonnes in first 3 quarters of 2025

Negative

• None.

Argus Dec 1 session

+0.38% close to close Open Argus

Details

News Market Reaction – HITI

In the Dec 1 session, HITI gained 0.38%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights High Tide’s first European Canna Cabana in Berlin, extending its 215-st...

Analysis

This announcement highlights High Tide’s first European Canna Cabana in Berlin, extending its 215-store Canadian base into Germany, a market of 83 million people and 143 tonnes of cannabis imports in early 2025. The move builds on the Remexian Pharma acquisition and supports a multi-channel strategy across retail, e-commerce, and medical distribution. Investors may watch for additional European store openings, regulatory developments in Germany, and updates on how international operations complement the company’s reported 12% Canadian market share.

Key Figures

Domestic Canna Cabana locations: 215 locations International Canna Cabana locations: 1 location Canadian market share: 12% +5 more

Domestic Canna Cabana locations

215 locations

Canadian bricks-and-mortar footprint cited in Berlin launch release

International Canna Cabana locations

1 location

First international Canna Cabana store in Berlin, Germany

Canadian market share

12%

Canna Cabana share across five Canadian provinces

German cannabis imports

143 tonnes

Imports in Germany during first three quarters of 2025

Remexian import countries

19 countries

Remexian Pharma licensed import reach for medical cannabis

Germany population

83 million people

Size of Germany referenced as Europe’s largest cannabis market

Cabana Club target members

3.0 million members

Long-term Cabana Club membership target as of Oct 21, 2025

Canadian retail cannabis sales

$5.5B

National retail cannabis sales for 12 months ending July 2025

Historical Context

5 past events · Latest: Dec 05

5 events

1. Dec 05

   Store openings Canada

   24h Move

   -3.6%

   Planned openings of three new Canna Cabana locations across Canada.

2. Dec 01

   European flagship launch

   24h Move

   +0.4%

   First European Canna Cabana flagship opened in Berlin, entering Germany.

3. Nov 12

   Multi-store expansion

   24h Move

   -1.0%

   Announcement of four new Canna Cabana stores in Alberta and Ontario.

4. Oct 23

   Single-store opening

   24h Move

   +0.6%

   New Hamilton, Ontario store to grow Ontario retail footprint.

5. Oct 21

   Loyalty milestone

   24h Move

   -0.3%

   Raised Cabana Club and store targets after strong loyalty growth.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

medical cannabis, forward-looking information, forward-looking statements, securities legislation, +1 more

5 terms

medical cannabis medical

"Remexian Pharma GmbH, a licensed medical cannabis importer and distributor..."

Medical cannabis is the use of cannabis plant extracts or compounds such as THC and CBD as prescribed or recommended to treat symptoms or medical conditions. Think of it as a plant-based medicine that can relieve pain, nausea, muscle spasms or other symptoms where conventional drugs may not work; for investors it matters because legal status, clinical evidence, supply rules and insurance coverage determine market size, licensing value and revenue potential.

forward-looking information regulatory

"This press release may contain "forward-looking information" and "forward-looking statements..."

Forward-looking information are predictions, plans, estimates or expectations about a company’s future performance, results or events, such as sales forecasts, project timelines, or anticipated costs. It matters to investors because these statements guide expectations but rely on assumptions and uncertain factors—like a weather forecast for a business—so investors should treat them as informed guesses rather than guarantees and consider the risks and possible changes behind the numbers.

forward-looking statements regulatory

"This press release may contain "forward-looking information" and "forward-looking statements..."

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

securities legislation regulatory

"...within the meaning of applicable securities legislation."

Laws and rules that govern how stocks, bonds and other investment products are issued, sold and traded, and what information companies must share with the public. These safeguards and disclosure requirements help prevent fraud, promote fair markets and shape costs and timelines for companies raising money; for investors they act like traffic rules for markets, reducing surprises and making it easier to compare risks and returns.

importation regulatory

"built for the purpose of importation and wholesale of medical cannabis products..."

Importation is the act of bringing goods, drugs, devices or services into a country from abroad for sale or use. Investors care because it affects a company’s supply chain, costs, pricing and access to markets — like a store that sources products from another city: if shipping, taxes, or rules change, profit margins and product availability can shift quickly.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

The Company Becomes First Publicly Traded North American Cannabis Operator to Set Up Bricks-and-Mortar Presence in Europe's Largest Cannabis Market

CALGARY, AB, Dec. 1, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that it has opened its first international Canna Cabana in Berlin, Germany—focused on cannabis accessories and consumer lifestyle goods—marking the brand's formal bricks-and-mortar entry into both Europe and the German market.

Located at Alte Schönhauser Str. 2, 10119 Berlin, the Company's newest Canna Cabana is situated in the heart of Berlin-Mitte, steps from Alexanderplatz, the political, cultural, and creative core of Berlin, and a globally recognized hub for fashion, food, art, and boutique retail. The surrounding area is home to marquee landmarks, including the Fernsehturm (TV Tower), Berlin Cathedral, Museum Island, and the rapidly expanding Hackescher Markt district.

This flagship store represents the first step in High Tide's broader European retail strategy, following its recent acquisition of Remexian Pharma GmbH, a licensed medical cannabis importer and distributor based in Germany. The Berlin opening reflects the Company's commitment to growing its European presence, which encompasses bricks-and-mortar retail, e-commerce, and medical cannabis distribution across key international markets.

"Canna Cabana's potential extends far beyond Canada, and this Berlin opening is the first step in unlocking that global opportunity. Germany, with more than 83 million people, is already Europe's largest and most influential cannabis market, with government data showing imports surpassing a record 143 tonnes in the first three quarters of 2025. As cannabis usage continues to accelerate, so too will demand for Canna Cabana's cutting-edge consumption accessories," said Raj Grover, Founder and Chief Executive Officer of High Tide.

"This bricks-and-mortar launch demonstrates our commitment to Germany for the long haul. We are closely following legislative and regulatory developments, and as Germany moves toward broader liberalization, Canna Cabana will have a meaningful head start. This is exactly how we built Canada's largest cannabis retailer—by establishing a loyal accessories following first, then seamlessly transitioning those customers into cannabis retail when the timing is right. Now, we're bringing that same winning formula to Europe," added Mr. Grover.

ABOUT HIGH TIDE

High Tide, Inc. is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world's most powerful plant. Its wholly owned subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally. High Tide (HITI) is uniquely-built around the cannabis consumer, with wholly-diversified and fully-integrated operations across all components of cannabis, including:

Retail: Canna Cabana™️ is the largest cannabis retail chain in Canada, with 215 domestic and 1 international location. The Company's Canadian bricks-and-mortar operations span British Columbia, Alberta, Saskatchewan, Manitoba, and Ontario, holding a growing 12% share of the market. In 2021, Canna Cabana became the first cannabis discount club retailer in the world. In 2025 The Company became the first North American cannabis operator to launch a bricks-and-mortar presence in Germany. The Company also owns and operates multiple global e-commerce platforms offering accessories and hemp-derived CBD products.

Medical Cannabis Distribution: Remexian Pharma GmbH is a leading German pharmaceutical company built for the purpose of importation and wholesale of medical cannabis products at affordable prices. Among all German medical cannabis procurers, Remexian has one of the most diverse reaches across the globe and is licensed to import from 19 countries including Canada.

High Tide consistently moves ahead of the currents, having been named one of Canada's Top Growing Companies by the Globe and Mail's Report on Business in 2025 for the fifth consecutive year and was recognized as a top 50 company by the TSX Venture Exchange in 2022, 2024 and 2025. High Tide was also ranked number one in the retail category on the Financial Times list of Americas' Fastest Growing Companies for 2023. To discover the full impact of High Tide, visit www.hightideinc.com. For investment performance, don't miss the High Tide profile pages on SEDAR+ and EDGAR.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

CONTACT INFORMATION

Media Inquiries
Carter Brownlee
Communications and Public Affairs Advisor
High Tide Inc.
cbrownlee@hightideinc.com
403-770-3080

Investor Inquiries
Vahan Ajamian
Capital Markets Advisor
High Tide Inc.
vahan@hightideinc.com

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This press release may contain "forward-looking information" and "forward-looking statements within the meaning of applicable securities legislation. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. The forward-looking statements herein include, but are not limited to, statements regarding: the expected benefits of the store locations, the level of competition in the area, the continued growth of the Company's European presence, cannabis usage in Germany continuing to accelerate, Germany making further moves towards liberalization, and the ability of the Company to establish a loyal accessories following and then transition to cannabis retail. Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements. Although the Company believes that the expectations reflected in these statements are reasonable, such statements are based on expectations, factors, and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond the Company's control, including but not limited to the risk factors discussed under the heading "Non-Exhaustive List of Risk Factors" in Schedule A to our current annual information form, and elsewhere in this press release, as such factors may be further updated from time to time in our periodic filings, available at www.sedarplus.ca and www.sec.gov, which factors are incorporated herein by reference. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results, or otherwise, or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

View original content to download multimedia:https://www.prnewswire.com/news-releases/high-tide-opens-first-european-canna-cabana-in-berlin-302628660.html

SOURCE High Tide Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did High Tide (HITI) announce on December 1, 2025 about Europe?

High Tide announced the opening of its first European Canna Cabana flagship store in Berlin and its broader European retail and distribution plans.

Where is High Tide's new Canna Cabana located in Berlin and when did it open?

The store opened on December 1, 2025 at Alte Schönhauser Str. 2, 10119 Berlin in the Berlin-Mitte area near Alexanderplatz.

How does High Tide's acquisition of Remexian affect HITI's European strategy?

The Remexian acquisition provides a licensed German medical cannabis importer and distributor and supports High Tide's planned bricks-and-mortar, e-commerce, and medical distribution presence in Europe.

What scale does High Tide report for its Canna Cabana retail footprint (HITI)?

High Tide reports 215 domestic Canna Cabana locations and 1 international location, with a reported 12% Canadian market share.

What import capacity or market data did High Tide cite for Germany (HITI)?

The company referenced German government data showing imports surpassed 143 tonnes in the first three quarters of 2025.

Will High Tide (HITI) expand Canna Cabana into cannabis retail in Germany immediately?

The company said it intends to follow a staged approach: building an accessories following first and expanding into cannabis retail as regulatory liberalization permits.